By using the results from Illumina 27k methylation array, we found that the group with high DNA methylation had significantly lower SLC4A11 expression, suggesting that epigenetic alterations also contribute to SLC4A11 upregulation in ovarian cancer. The gene discussed is SLC4A11; the disease is ovarian carcinoma.